Some of this article's listed sources may not be reliable. Please help improve this article by looking for better, more reliable sources. Unreliable citations may be challenged and removed.(May 2023) (Learn how and when to remove this message)
Iris Löw-Friedrich (chairwoman of the Supervisory Board)
Revenue
618 million € (2021)[1]
Number of employees
>4,200 (2021)[1]
Website
evotec.com
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion[2] and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.[3]
The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology (e.g. Alzheimer's disease, Huntington's disease), metabolic diseases (e.g. Diabetes), Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb,[4] Bayer,[5] Sanofi,[6] Boehringer Ingelheim,[7] the CHDI Foundation,[8] Lilly,[9] Takeda,[10] Sernova,[11] and more.
On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector.[12] On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing.[13] The MDAX tracks 60 Prime Standard shares from sectors excluding technology.[14] On 8 November 2021, Evotec completed its secondary listing on the U.S. Nasdaq stock exchange on November 8 and raised $500 million.[15]
^"Evotec 2021 Annual Report" (PDF). evotec.com. Retrieved 12 April 2022.
^"Evotec 2021 Annual Report" (PDF). evotec. Retrieved 12 April 2022.
^"Evotec, Celgene Partner on Targeted Protein Degradation for Drug Discovery". GenomeWeb. Retrieved 5 December 2018.
^"Bayer and Evotec Extend their Endometriosis Partnership". labiotech.eu. 24 July 2017. Retrieved 5 December 2018.
^"Sanofi, Evotec in major infectious disease R&D transfer and license deal". FierceBiotech. Retrieved 24 November 2018.
^"Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology". Evotec. Retrieved 25 January 2022.
^"Evotec and CDHI form Huntington Disease alliance". Outsourcing-Pharma. Retrieved 24 November 2018.
^"Evotec and Lilly enter into drug discovery collaboration in metabolic diseases". Evotec. Retrieved 18 January 2022.
^"Evotec and Takeda enter strategic RNA targeting drug discovery and development alliance". Evotec. Retrieved 22 March 2021.
^"Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a 'functional cure' for diabetes". bionity. Retrieved 19 May 2022.
^"Evotec Share". Boerse Frankfurt. Retrieved 13 December 2018.
^"Evotec AG listed in MDAX".
^"MDAX". Deutsche Boerse. Retrieved 13 December 2018.
^"Evotec completed US IPO". Deutsche Boerse Cash Market. Retrieved 9 November 2021.
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through...
Improvision, Evotec-Technologies, Euroscreen, ViaCell, and Avalon Instruments. The brand "Evotec-Technologies" remains the property of Evotec, the former...
Carl Zeiss Meditec CompuGroup Medical SE Deutsche Telekom Energiekontor Evotec Freenet Hensoldt Infineon Technologies Jenoptik Kontron MorphoSys Nagarro...
phase I clinical trials. For this reason, it was subsequently licensed to Evotec, which is now developing it for the treatment of insomnia. By 2007, dimdezenil...
offices are also in Milton Park. Pharmaceutical companies are represented by Evotec, Vertex Pharmaceuticals, Hypha Discovery, Immunocore among others. Milton...
Klys (14 July 2019). "Using Lansweeper with PowerShell to your advantage – Evotec". Archived from the original on 22 October 2019. Retrieved 22 October 2019...
with Peter Schuster in 1977. Eigen founded two biotechnology companies, Evotec and Direvo. In 1981, Eigen became a founding member of the World Cultural...
The Verge. Retrieved February 21, 2018. Sanofi. "Evotec and Sanofi in exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform"...
calcification disorders in Chronic Kidney Disease. Nephtera is a joint venture with Evotec to build a nephrology therapeutic pipeline. Iron deficiency is a condition...
medicine for autoimmune and inflammatory diseases, in 2014 with German company Evotec to identify and develop compounds to treat a variety of cancers, or with...
are phased out. Deutsche Bank, member of the advisory board (2011-2017) Evotec AG, member of the supervisory board (2011-2014) NRW.BANK, Ex-Officio member...
NMDA antagonist in treatment-resistant depression voluntarily terminated". evotec.com. 2011-05-18. Retrieved 2015-08-24. Wyszynski M, Lin J, Rao A, Nigh E...
Lambda Physik (today part of Coherent), DeveloGen (today part of Evotec) and Evotec. Research at the institute focuses on the fundamental mechanisms that...
to French laboratory Neuro3D and then acquired in 2007 by German company Evotec. It was found to be more potent than risperidone in animal studies, but...
research approaches, including Eurofins Discovery Phenotypic Services, Evotec, Dharmacon, Inc., ThermoScientific, Cellecta, and Persomics. The pharmaceutical...
"Software AG to buy IDS for 487 million euros". Reuters. Retrieved 2009-11-02. "Evotec up; probable Tecdax inclusion". Reuters. 6 October 2009. Retrieved 2009-11-02...
co-funded the biopharmaceutical company DeveloGen AG in Göttingen (now part of Evotec) in 1997, together with fellow developmental biologists Herbert Jaeckle [de]...
Global Information
